Skeletal effects of sodium fluoride during hypokinesia

Louis S. Kidder, Gordon L. Klein, Charles A. Stuart, Thomas C. Lee, Caren M. Gundberg, Nancy Alcock, Cary W. Cooper, David J. Simmons

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


This study tested the capacity of fluoride (F) to prevent the disuse-associated reduction in bone formation/growth. Suspending young male Wistar rats by the tail for 2-2.5 weeks reduced femoral cortical (P < 0.05) and trabecular (P < 0.01) bone areas. Tetracycline labelling showed that the decrement in cortical area was largely due to a reduction in the percent periosteal mineralizing surface (PsMS). Periosteal mineral apposition rate (PsMAR) was not affected. Endosteal mineralizing surface (EsMS) and mineral apposition rate (EsMAR) were significantly stimulated spontaneously during the second week of suspension. F treatment (5 mg/kg/day i.p.) prevented the loss in bone area, and established a trend toward increased PsMS without affecting EsMS and EsMAR. None of these changes are associated with alterations in serum Ca, P or osteocalcin. F treatment in hypokinetic animals caused a decrease in serum PTH (-21% compared to control; P = 0.001). We conclude that F prevents the development of hypokinetic osteopenia in rats.

Original languageEnglish (US)
Pages (from-to)305-318
Number of pages14
JournalBone and Mineral
Issue number3
StatePublished - Dec 1990


  • Fluoride
  • Hypokinetic osteopenia
  • Osteoblast


Dive into the research topics of 'Skeletal effects of sodium fluoride during hypokinesia'. Together they form a unique fingerprint.

Cite this